Not only does reactivating wild-type (wt) p53 have an influential role in the p53 restoration, but also stabilizing p53, for instance, using MDM2 inhibitors in wt p53-expressing cancer cells, has shown promising results. The gene discussed is MDM2; the disease is cancer.